GR3005794T3 - - Google Patents

Info

Publication number
GR3005794T3
GR3005794T3 GR920402116T GR920402116T GR3005794T3 GR 3005794 T3 GR3005794 T3 GR 3005794T3 GR 920402116 T GR920402116 T GR 920402116T GR 920402116 T GR920402116 T GR 920402116T GR 3005794 T3 GR3005794 T3 GR 3005794T3
Authority
GR
Greece
Application number
GR920402116T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Application filed filed Critical
Publication of GR3005794T3 publication Critical patent/GR3005794T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
GR920402116T 1989-04-11 1992-09-24 GR3005794T3 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (1)

Publication Number Publication Date
GR3005794T3 true GR3005794T3 (en:Method) 1993-06-07

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402116T GR3005794T3 (en:Method) 1989-04-11 1992-09-24

Country Status (16)

Country Link
EP (1) EP0393890B1 (en:Method)
JP (1) JPH0647548B2 (en:Method)
CN (1) CN1035356C (en:Method)
AP (1) AP133A (en:Method)
AU (1) AU609660B2 (en:Method)
CY (1) CY1777A (en:Method)
DK (1) DK0393890T3 (en:Method)
EG (1) EG18956A (en:Method)
ES (1) ES2052173T3 (en:Method)
FI (1) FI92015C (en:Method)
GR (1) GR3005794T3 (en:Method)
HK (1) HK39294A (en:Method)
NO (1) NO175882C (en:Method)
OA (1) OA09203A (en:Method)
RU (1) RU1836084C (en:Method)
SG (1) SG27894G (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
ATE252316T1 (de) * 1996-06-05 2003-11-15 Ashmont Holdings Ltd Injizierbare zusammensetzungen
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
NZ590141A (en) * 2008-06-24 2012-05-25 Merial Ltd Anthelminthic formulations including castor oil and another vegetable oil
NZ594389A (en) * 2009-02-16 2012-09-28 Pfizer Antiparasitic composition comprising doramectin, cottonseed oil and benzyl benzoate
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8504457A (pt) * 1984-09-14 1986-07-15 Glaxo Group Ltd Processos para a preparacao de um composto e de uma composicao para combater infeccoes ou infestacoes
IL78621A (en) * 1985-04-30 1991-06-30 American Cyanamid Co Mylbemycin analogs,their preparation and pesticidal compositions containing them
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
DE3880088T2 (de) * 1987-11-09 1993-07-22 Pfizer Ethylierte avermectine.

Also Published As

Publication number Publication date
DK0393890T3 (da) 1992-09-28
NO901637L (no) 1990-10-12
EP0393890B1 (en) 1992-08-12
NO175882C (no) 1994-12-28
HK39294A (en) 1994-05-06
AU609660B2 (en) 1991-05-02
CY1777A (en) 1995-10-20
OA09203A (fr) 1992-06-30
NO901637D0 (no) 1990-04-10
AU5311990A (en) 1990-11-08
EP0393890A1 (en) 1990-10-24
NO175882B (no) 1994-09-19
FI92015C (fi) 1994-09-26
RU1836084C (ru) 1993-08-23
CN1046282A (zh) 1990-10-24
FI901816A0 (fi) 1990-04-10
CN1035356C (zh) 1997-07-09
JPH02290820A (ja) 1990-11-30
ES2052173T3 (es) 1994-07-01
SG27894G (en) 1995-03-17
AP133A (en) 1991-06-05
EG18956A (en) 1994-04-30
JPH0647548B2 (ja) 1994-06-22
FI92015B (fi) 1994-06-15
AP9000174A0 (en) 1990-04-30

Similar Documents

Publication Publication Date Title
DE4091170T (en:Method)
DE4090376A1 (en:Method)
DE4091302T1 (en:Method)
DE4091209T (en:Method)
DE4090626T (en:Method)
DE4090852T (en:Method)
US5055722B1 (en:Method)
DE4090652T (en:Method)
DE4090873T (en:Method)
DE4090909A1 (en:Method)
DE4091298T (en:Method)
GR3005794T3 (en:Method)
DE4090739T (en:Method)
FR2652904B1 (en:Method)
DE4091342T (en:Method)
FR2649149B3 (en:Method)
ATA277289A (en:Method)
DE4091278D2 (en:Method)
DE4090439T (en:Method)
FR2643255B3 (en:Method)
ATA295789A (en:Method)
DE4090967A1 (en:Method)
DE4090929D2 (en:Method)
FR2644909B1 (en:Method)
AU2141188A (en:Method)